VANGUARD CAPITAL WEALTH ADVISORS Nautilus Biotechnology, Inc. Transaction History

VANGUARD CAPITAL WEALTH ADVISORS portfolio value:

$48,000
portfolio value

VANGUARD CAPITAL WEALTH ADVISORS quarter portfolio value change:

-21.19%
quarter

Nautilus Biotechnology, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.02% -1.7K shares -17K $2.12 22.5K
Q2 2022 share Decrease -9.36% -2.5K shares -50K $2.69 24.2K
Q1 2022 share Decrease -41.32% -18.8K shares -120K $4.34 26.7K
Q4 2021 share Increase 0.00% 45.5K shares 235K $5.35 45.5K